CTI BioPharma Corp.
CTIC · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$17 | -$16 | -$23 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $3 | $3 | $3 |
| Change in WC | -$23 | -$4 | -$5 | -$3 |
| Other Non-Cash | $3 | $3 | $2 | $2 |
| Operating Cash Flow | -$31 | -$16 | -$15 | -$20 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | -$29 | -$30 | $0 |
| Inv. Sales/Matur. | $30 | $30 | $10 | $0 |
| Other Inv. Act. | $0 | $30 | $0 | -$55 |
| Investing Cash Flow | $15 | $1 | -$20 | -$55 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $10 | $0 | $44 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10 | $13 | $1 | $0 |
| Financing Cash Flow | $10 | $13 | $1 | $44 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | -$2 | -$34 | -$31 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30 | $32 | $66 | $97 |
| End Cash | $24 | $30 | $32 | $66 |
| Free Cash Flow | -$31 | -$16 | -$15 | -$20 |